HEPATITIS B REACTIVATION IN PATIENTS WITH NON HODGKIN LYMPHOMA CD20+ UNDERGOING CHEMOTHERAPY

被引：0
|
作者：
De Renzo, A. [1 ]
Masarone, M. [2 ]
Persico, M. [2 ]
Perna, F. [1 ]
Cuccurullo, R. [1 ]
Alfinito, F. [3 ]
Picardi, M. [1 ]
Del Vecchio, L. [1 ]
Luponio, S. [1 ]
Martinelli, V. [1 ]
Pane, F. [1 ]
机构：
[1] Univ Federicoll Naples, Naples, Italy
[2] Univ Naples 2, Naples, Italy
[3] It Hematol Div, Naples, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0285
引用
收藏
页码：113 / 113
页数：1
相关论文
共 50 条
  • [1] HEPATITIS B REACTIVATION IN PATIENTS WITH NON HODGKIN LYMPHOMA CD 20+IN MAINTENANCE THERAPY WITH RITUXIMAB
    De Renzo, A.
    Luponio, S.
    Ferrara, I.
    Della Pepa, R.
    Migliaccio, I.
    Beneduce, G.
    Cimmino, C.
    Cuccurullo, R.
    Picardi, M.
    Masarone, M.
    Persico, M.
    Pane, F.
    HAEMATOLOGICA, 2013, 98 : 645 - 645
  • [2] LAMIVUDINE FOR PREVENTION OF REACTIVATION IN OCCULT HEPATITIS B IN PATIENTS WITH NON-HODGKIN LYMPHOMA CD20+UNDERGOING CHEMOTHERAPY: A COST-EFFECTIVE ANALYSIS
    Cerchione, C.
    De Renzo, A.
    Masarone, M.
    Cimmino, C.
    Di Perna, M.
    Signoriello, G.
    Persico, M.
    Pane, F.
    HAEMATOLOGICA, 2016, 101 : 838 - 839
  • [3] COST-EFFECTIVE ANALYSIS OF PROPHYLAXIS WITH LAVIVUDINE FOR PREVENTION OF REACTIVATION IN OCCULT HEPATITIS B (OBI) IN PATIENTS WITH NON HODGKIN LYMPHOMA CD20+UNDERGOING CHEMOTHERAPY
    Cerchione, C.
    De Renzo, A.
    Masarone, M.
    Cimmino, C.
    Raimondo, M.
    Signoriello, G.
    Notarangelo, M.
    Giagnuolo, G.
    Persico, M.
    Pane, F.
    HAEMATOLOGICA, 2015, 100 : 580 - 581
  • [4] COST-EFFECTIVE ANALYSIS OF PROPHYLAXIS WITH LAMIVUDINE FOR PREVENTION OF REACTIVATION IN OCCULT HEPATITIS B IN PATIENTS WITH NON-HODGKIN LYMPHOMA CD20+UNDERGOING CHEMOTHERAPY
    Cerchione, C.
    De Renzo, A.
    Masarone, M.
    Cimmino, C.
    Raimondo, M.
    Signoriello, G.
    Notarangelo, M.
    Giagnuolo, G.
    Persico, M.
    Pane, F.
    HAEMATOLOGICA, 2015, 100 : 72 - 73
  • [5] EFFECT OF 1B8 ON THE TREATMENT OF PATIENTS WITH NON-HODGKIN LYMPHOMA CD20+
    Saumell Napoles, Y.
    VALUE IN HEALTH, 2017, 20 (09) : A872 - A872
  • [6] PREVALENCE OF HEPATITIS B REACTIVATION IN PATIENTS WITH INDOLENT NON HODGKIN LYMPHOMA CD20+DURING MAINTENANCE THERAPY WITH RITUXIMAB
    Giagnuolo, G.
    Raimondo, M.
    Cimmino, C.
    Della Pepa, R.
    Luponio, S.
    Beneduce, G.
    Cerchione, C.
    Masarone, M.
    Persico, M.
    Pane, F.
    De Renzo, A.
    HAEMATOLOGICA, 2015, 100 : 706 - 706
  • [7] MAINTENANCE THERAPY WITH RITUXIMAB IN PATIENT WITH INDOLENT NON HODGKIN LYMPHOMA CD20+: IS IT A RISK FACTOR FOR HBV REACTIVATION?
    Giagnuolo, G.
    Raimondo, M.
    Cimmino, C.
    Della Pepa, R.
    Luponio, S.
    Madonna, E.
    Cerchione, C.
    Masarone, M.
    Persico, M.
    Pane, F.
    De Renzo, A.
    HAEMATOLOGICA, 2015, 100 : 155 - 155
  • [8] Hepatitis B Reactivation in Patients Undergoing Chemotherapy
    Artac, Mehmet
    Eren, Orhan Onder
    Boruban, Melih Cem
    Inkaya, Ahmet Cagkan
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2010, 16 (02): : 69 - 76
  • [9] The status of radioimmunotherapy in CD20+ non-Hodgkin’s lymphoma
    Evan D. Read
    Peter Eu
    Peter J. Little
    Terrence J. Piva
    Targeted Oncology, 2015, 10 : 15 - 26
  • [10] IS THERE A REAL INCRESED PREVALENCE OF HEPATITIS B REACTIVATION IN PATIENTS WITH CD20+INDOLENT NON HODGKIN LYMPHOMA DURING MAINTENANCE WITH RITUXIMAB?
    Vitagliano, O.
    Trastulli, F.
    Simeone, L.
    Russo, V.
    Marano, L.
    Raimondo, M.
    Cimmino, C.
    Della Pepa, R.
    Giagnuolo, G.
    Luponio, S.
    Beneduce, G.
    Cerchione, C.
    Masarone, M.
    Persico, M.
    De Renzo, A.
    Pane, F.
    HAEMATOLOGICA, 2016, 101 : 753 - 753
12345